Skip to content

Therapeutic Outcomes Of Dry Needling Coupled With Intramuscular Stimulation In Patients With Fibromyalgia Syndrome

Therapeutic Outcomes Of Dry Needling Coupled With Intramuscular Stimulation In Patients With Fibromyalgia Syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240125060803N1
Enrollment
78
Registered
2024-06-01
Start date
2024-06-10
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia Syndrome. Fibromyalgia

Interventions

Intervention 1: Intervention group: Dry Needling With Intramuscular Electrical Stimulation. Intervention 2: Control group: Dry Needling Group.

Sponsors

The university of lahore
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Both male and female patients Age over 18 years and under 60 years Pre diagnosed patients with FMS referred through consultant Manifesting chronic widespread musculoskeletal pain symptoms Presence of active trigger points, as confirmed by physical examination Willing and able to provide informed consent to participate in the study. Ability to understand and comply with the study requirements No contraindications to dry needling or IMS

Exclusion criteria

Exclusion criteria: Pregnancy or breastfeeding Use of any medications that could interfere with the study results (e.g. muscle relaxants, opioids) within the past 48 hours. Previous treatment with dry needling or IMS within the past 6 months Presence of any other conditions that could interfere with the study results (e.g. cancer, infection) Participation in any other clinical trials within the past 30 days Anatomical anomaly Structural disorder of spinal alignment (Scoliosis, kyphosis, lordosis)o Any bone abnormality in neck region Traumatic/ Inflammatory/ Infectious Conditions such as Recent Trauma, Nerve root compromise, Metabolic or serious spinal pathologies (e.g., fractures, tumors, inflammatory, and infectious diseases), Previous neck surgery Psycho-social Instability such as Diagnosed stress/ depression/ Anxiety Risk Profile such as High Risk Inability to understand or comply with the study requirements, as determined by the physiotherapist

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: Baseline screening, Assessment at 2nd week interval, Assessment at 4th week interval, Follow up at 8th week interval. Method of measurement: Numeric Pain Rating Scale.;Pressure. Timepoint: Baseline screening, Assessment at 2nd week interval, Assessment at 4th week interval, Follow up at 8th week interval. Method of measurement: Pain pressure threshold; algometer.;Anxiety depression. Timepoint: Baseline screening, Assessment at 2nd week interval, Assessment at 4th week interval, Follow up at 8th week interval. Method of measurement: Hospital Anxiety and Depression Scale (HADS).;Quality of Sleep. Timepoint: Baseline screening, Assessment at 2nd week interval, Assessment at 4th week interval, Follow up at 8th week interval. Method of measurement: Pittsburgh Sleep Quality Index (PSQI).;Fatigue. Timepoint: Baseline screening, Assessment at 2nd week interval, Assessment at 4th week interval, Follow up at 8th week interval. Method of measurement: Multidimensional Fatigue Inventory (MFI).

Countries

Pakistan

Contacts

Public ContactMuhammad Asim Arif

The University of Lahore

asim.arif@uipt.uol.edu.pk+92 321 6597727

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026